UK Life Sciences Firms Struggle in Post-Brexit War for EU Talent
UK pharmaceutical and biotech companies are already finding it increasingly difficult to attract talent from…
Brexit
NHS England’s Long-Term Plan to be Funded by £20.5…
Today NHS England have released their long-term plan to ensure the future of the NHS and the continued care of UK patients. The plan is backed by 20.5 billion…
NEW Special Report on UK
Despite a myriad of uncertainties around its decision to leave the European Union, the UK still stands as one of…
The European Medicines Verification System Launches to Tackle Fake Drugs
The 9th February 2019 marked the launch of the European Medicines Verification System (EMVS) which will use…
In Conversation
Interview: Erik Nordkamp – Managing Director, Pfizer UK
Erik Nordkamp, managing director of Pfizer UK shares his thoughts on the future of healthcare and the role that Pfizer and the UK can play in shaping it. He explains why the momentum is right for the UK to lead the way in sustainable healthcare and how it can remain a reference market post-Brexit. Can you please introduce the scope…
Brexit Facts & Figures Snapshot
There is much debate surrounding the potential impact on the UK’s life sciences industry of the…
Related Report
Pfizer’s Nordkamp Takes ABPI Presidency
Erik Nordkamp, managing director of Pfizer UK, has been confirmed as the new president of the Association of the…
Europe: Political Complexity Bodes Poorly for Pharma
Aditya Bhattacharji takes a look at the potentially damaging impact of political uncertainty across Europe –…
Brexit: Much ado about nothing?
Brexit, Brexit, Brexit. It’s all anyone can talk about and yet nobody can tell you with certainty what to expect.…
Roche boss: Brexit will make the UK less competitive
Last week, Roche Boss Severin Schwan expressed concern that Brexit could further slow the UK drug approval process.…
Brexit: A Serious Threat to Patients
As the UK extracts itself from the European Union, key figures from the country’s life sciences sector are…
Brexit uncertainty forces AstraZeneca to freeze investment in the UK
Yesterday, pharma giant AstraZeneca announced that they have halted investment in the UK due to lack of clarity on…
Brexit Bites: EMA cuts off Britain
The European Medicines Agency has cut Britain out of its contracts 7 months ahead of Brexit. “You might have been…